Midterm results of primary vs. secondary laparoscopic sleeve gastrectomy (LSG) as an isolated operation

Obes Surg. 2009 Apr;19(4):401-6. doi: 10.1007/s11695-009-9804-z. Epub 2009 Jan 24.

Abstract

Background: We investigated early and midterm results of laparoscopic sleeve gastrectomy (LSG) as an isolated primary and secondary operation after failed gastric banding.

Methods: Between May 2004 and October 2007, a total of 70 patients (female 77%, mean age 43 (21-65) years, mean initial body mass index (BMI) 46 (35-61) kg/m(2)) were prospectively evaluated and operated by LSG. In 41 patients, LSG was performed as a primary operation (group 1) and in 29 patients as a secondary procedure after failed gastric banding (group 2). The overall average follow-up time after LSG was 24 (12-53) months; follow-up rate 1 year after operation was 100%, after 2 years 98%, and after 3 years 95%.

Results: There were no intraoperative complications, no conversion with shorter operation time in group 1 (91 vs. 132 min, p = 0.001). Early morbidity of LSG was 5% (major) and 7% (minor); mortality was zero. Average excessive BMI loss after 1 year was 65% (9-127%), after 2 years 63% (13-123%), and after 3 years 60% (9-111%). Midterm morbidity was 13%. There was no significant difference between the two groups regarding early and midterm morbidity, reoperation rate for complications (11.4%), or insufficient weight loss (7%).

Conclusions: LSG is a safe bariatric procedure with good weight loss in the first 3 years postop. It can be used as an isolated initial treatment and as a secondary treatment after failed gastric banding. However, in the absence of long-term results, we suggest LSG to be performed only in controlled trials.

MeSH terms

  • Adult
  • Aged
  • Body Mass Index
  • Female
  • Gastrectomy / methods*
  • Gastroplasty
  • Humans
  • Male
  • Middle Aged
  • Obesity, Morbid / surgery
  • Reoperation
  • Treatment Failure
  • Treatment Outcome
  • Young Adult